Pricing Log in Create free account

Brainstorm Cell Therapeutics Inc. (BCLI) vs Exicure, Inc. (XCUR)

Brainstorm Cell Therapeutics Inc. and Exicure, Inc. are both Biotechnology companies. Brainstorm Cell Therapeutics Inc. and Exicure, Inc. are of similar size ($7.3M and $7.0M). Across the 9 metrics below, Exicure, Inc. leads on 5 and Brainstorm Cell Therapeutics Inc. on 4.

Valuation

Metric BCLI XCUR Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.26 9.71
P/B n/m 7.24 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 0.24 9.21
Earnings yield (119.40%) (118.92%) (33.15%)
Free cash flow yield (47.20%) (84.13%) (25.50%)

Profitability

Metric BCLI XCUR Biotechnology median
Gross margin 0.00% 80.08% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 119.20% (168.37%) (56.36%)
Return on assets (627.43%) (54.98%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BCLI XCUR Biotechnology median
Revenue growth (TTM) — 2,366.45% 6.02%
EPS growth (last fiscal year) 51.95% 83.37% 30.26%
Revenue growth, 5-year CAGR — 33.48% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCLI XCUR Biotechnology median
Debt to equity (0.11) 0.00 0.00
Current ratio 0.03 0.56 4.72
Net debt to EBITDA (0.10) 0.99 0.96

Dividend

Metric BCLI XCUR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BCLI XCUR Biotechnology median
Market cap 6.99m 7.33m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack